The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer
Thomas Powles, Siobhan McFaul, Justin Stebbing, Peter Wilson, Tim Oliver, Naomi Tranter, Jonathan ShamashDepartment of Medical Oncology, St Bartholomew’s Hospital, London, United KingdomBackground: Sunitinib is widely used as first-line treatment for metastatic clear cell...
Main Authors: | Thomas Powles, Siobhan McFaul, Justin Stebbing, Peter Wilson, Tim Oliver et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-09-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/the-efficacy-and-safety-of-irinotecan-cisplatin-and-mitomycin-chemothe-a2321 |
Similar Items
-
Irinotecan Plus Mitomycin C as Second-Line Chemotherapy for Advanced Gastric Cancer Resistant to Fluoropyrimidine and Cisplatin: A Retrospective Study
by: Kohei Ogawa, et al.
Published: (2012-01-01) -
A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer
by: Shamash, J., et al.
Published: (2008) -
Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient
by: J Verwimp, et al.
Published: (2010-05-01) -
CAPECITABINE AND IRINOTECAN AS FIRST- LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2010-11-01) -
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy
by: Kyunghye Bang, et al.
Published: (2021-03-01)